Hospira intends to redeem 5.9%, 6.4% notes via new offerings proceeds

By Tali David

Minneapolis, Aug. 7 - Hospira Inc. plans to redeem all of it $400 million outstanding aggregate principal amount of 5.9% notes due June 2014 and $250 million outstanding aggregate principal amount of 6.4% notes due May 2015 with the proceeds of two new note offerings, according to a 424B3 filed with the Securities and Exchange Commission.

The notes will be redeemed at a price equal to the make-whole redemption price plus accrued interest to the redemption date.

Hospira is a specialty pharmaceutical and medication delivery company based in Lake Forest, Ill.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.